BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:ARO-RAGE readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of ARO-RAGE\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07241546-3744@assetmemo.bio
DTSTAMP:20261121T004547Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:ARO-RAGE: Phase 2 readout est. (NCT07241546)
DESCRIPTION:ARO-RAGE\, phase 2\, Asthma.\nStudy: Study of Inhaled ARO-RAGE 
 in Allergen-induced Mild Asthma\nEstimated primary completion: December 20
 27. This is a ClinicalTrials.gov estimate\, not a confirmed readout date\,
  and it can move.\nDrug page: https://assetmemo.bio/drug/aro-rage#upcoming
 -events\nRegistry record: https://clinicaltrials.gov/study/NCT07241546
URL:https://assetmemo.bio/drug/aro-rage#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
